| P50 | author | Angela M Hall | Q57320141 |
| P2093 | author name string | Brian N Finck | |
| | Nathan Qi | |
| | Mayurranjan S Mitra | |
| | Jerry R Colca | |
| | Zhouji Chen | |
| | Kari T Chambers | |
| | William G McDonald | |
| | Rolf F Kletzien | |
| | Patrick A Vigueira | |
| P2860 | cites work | Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance | Q24555727 |
| | Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes | Q24683425 |
| | Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe | Q28211498 |
| | Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor | Q28250779 |
| | A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides | Q28507306 |
| | MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity | Q28507474 |
| | Muscle-specific Pparg deletion causes insulin resistance | Q28508726 |
| | Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway | Q28510620 |
| | An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 |
| | Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion | Q30439917 |
| | Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart | Q31939734 |
| | Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention | Q33878917 |
| | Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system | Q33935032 |
| | Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 |
| | Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review | Q34100675 |
| | Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. | Q34330155 |
| | The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. | Q34522920 |
| | Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). | Q34587610 |
| | Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle | Q34790967 |
| | Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes | Q34835012 |
| | Regulation of PPARgamma activity during adipogenesis | Q36042255 |
| | Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? | Q36144641 |
| | Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus | Q36390892 |
| | Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events | Q37240896 |
| | Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study | Q37310162 |
| | An emerging role of mTOR in lipid biosynthesis. | Q37641438 |
| | Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways | Q38316513 |
| | Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists | Q38318111 |
| | Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase | Q39934578 |
| | Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice | Q42575432 |
| | PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein | Q42826174 |
| | Rosiglitazone or pioglitazone in type 2 diabetes? | Q43289984 |
| | Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile | Q43737515 |
| | Hepatic fatty acid synthesis is suppressed in mice with fatty livers due to targeted apolipoprotein B38.9 mutation | Q43909354 |
| | Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. | Q44477314 |
| | The outer mitochondrial membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster | Q44582287 |
| | A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes | Q46473134 |
| | Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption | Q46592677 |
| | A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes | Q46626385 |
| | What has prevented the expansion of insulin sensitisers? | Q46965009 |
| | Acute effects of pioglitazone on glucose metabolism in perfused rat liver. | Q54152312 |
| | The safety of rosiglitazone in the treatment of Type 2 diabetes | Q57413490 |
| | DNA excision in liver by an albumin-Cre transgene occurs progressively with age | Q61203358 |
| | Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver | Q77134058 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 28 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| | obesity | Q12174 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 23537-23548 | |
| P577 | publication date | 2012-05-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione | |
| P478 | volume | 287 | |